OTC:HRGN | Free Cash Flow | Harvard Apparatus Regenerative Technology, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$937,000.00
2025-12-31-$664,000.00
2025-03-31-$758,000.00
2024-12-31-$1.13M
2024-03-31-$960,000.00
2023-12-31-$1.22M$0.00-$1.22M
2023-03-31-$1.01M$9,000.00-$1.02M
2022-12-31-$1.73M-$3,000.00-$1.74M
2022-03-31-$519,000.00
2021-12-31-$1M$0.00-$1M
2021-03-31-$560,000.00
2020-12-31-$1.02M$0.00-$1.02M
2020-03-31-$1.09M$0.00-$1.09M
2019-12-31-$1.44M$11,000.00-$1.45M
2019-03-31-$1.22M$24,000.00-$1.24M
2018-12-31-$2.18M$4,000.00-$2.19M
2018-03-31-$2.06M$3,000.00-$2.06M
2017-12-31-$1.65M-$4,000.00-$1.66M
2017-03-31-$3.06M$105,000.00-$3.16M
2016-12-31-$2.99M$77,000.00-$3.07M
2016-03-31-$2.48M$128,000.00-$2.61M
2015-12-31-$1.62M$1,000.00-$1.63M
2015-03-31-$1.69M$6,000.00-$1.69M
2014-12-31-$2.32M$131,000.00-$2.45M
2014-03-31-$1.41M$242,000.00-$1.65M
2013-12-31-$2.09M$150,000.00-$2.24M
2013-03-31-$1.93M$18,000.00-$1.95M
2012-12-31-$1.53M$164,000.00-$1.69M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$3.83M
2024-12-31-$4.85M$0.00-$4.85M
2023-12-31-$6.94M$11,000.00-$6.95M
2022-12-31-$5.11M$5,000.00-$5.11M
2021-12-31-$2.63M$0.00-$2.63M
2020-12-31-$4.04M$7,000.00-$4.05M
2019-12-31-$6.06M$129,000.00-$6.19M
2018-12-31-$7.64M$131,000.00-$7.77M
2017-12-31-$11.01M$136,000.00-$11.15M
2016-12-31-$9.06M$302,000.00-$9.36M
2015-12-31-$7.19M$176,000.00-$7.36M
2014-12-31-$7.99M$1.16M-$9.16M
2013-12-31-$7.69M$295,000.00-$7.98M
2012-12-31-$5.9M$310,000.00-$6.21M